Galena Biopharma Company Profile (NASDAQ:GALE)

About Galena Biopharma

Galena Biopharma logoGalena Biopharma, Inc. is a biopharmaceutical company. The Company focuses on developing and commercializing targeted oncology therapeutics that address unmet medical needs. The Company's development portfolio ranges from mid- to late-stage clinical assets, including cancer immunotherapy program led by NeuVax (nelipepimut-S), GALE-301 and GALE-302. The Company's NeuVax is in Phase III breast cancer clinical trial with several concurrent Phase II trials ongoing both as a single agent and in combination with other therapies. GALE-301 is in a Phase IIa clinical trial in ovarian and endometrial cancers and in a Phase Ib clinical trial given sequentially with GALE-302. The Company's therapies utilize an immunodominant peptide combined with the immune adjuvant, recombinant human granulocyte macrophage-colony stimulating factor (rhGM-CSF, Leukine), and work by harnessing the patient's own immune system to seek out and attack any residual cancer cells.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: GALE
  • CUSIP:
Key Metrics:
  • Previous Close: $0.33
  • 50 Day Moving Average: $0.3857
  • 200 Day Moving Average: $1.0331
  • 52-Week Range: $0.28 - $2.49
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -2.35
  • P/E Growth: 0.0000
  • Market Cap: $71.32M
  • Outstanding Shares: 213,968,000
  • Beta: 1.92
Profitability:
  • Return on Equity: -112.93%
  • Return on Assets: -29.13%
Debt:
  • Current Ratio: 0.96%
  • Quick Ratio: 0.96%
Additional Links:
Companies Related to Galena Biopharma:

Analyst Ratings

Consensus Ratings for Galena Biopharma (NASDAQ:GALE) (?)
Ratings Breakdown: 3 Hold Ratings, 4 Buy Ratings
Consensus Rating:Buy (Score: 2.57)
Consensus Price Target: $2.55 (675.82% upside)

Analysts' Ratings History for Galena Biopharma (NASDAQ:GALE)
Show:
DateFirmActionRatingPrice TargetDetails
9/20/2016S&P Equity ResearchLower Price Target$0.39 -> $0.34View Rating Details
8/16/2016FBR & CoReiterated RatingOutperform$2.00View Rating Details
8/10/2016Maxim GroupLower Price TargetBuy$2.00 -> $1.00View Rating Details
6/29/2016Noble FinancialDowngradeBuy -> HoldView Rating Details
6/29/2016Raymond James Financial Inc.DowngradeOutperform -> Market PerformView Rating Details
6/9/2016Roth CapitalReiterated RatingBuy$5.00View Rating Details
1/22/2016Oppenheimer Holdings Inc.Reiterated RatingOutperform$4.00View Rating Details
12/8/2015Cantor FitzgeraldUpgradeSell -> Hold$2.00View Rating Details
8/7/2015MLV & Co.Reiterated RatingBuy$5.00View Rating Details
3/6/2015Needham & Company LLCSet Price TargetBuy$7.00 -> $4.00View Rating Details
(Data available from 9/30/2014 forward)

Earnings

Earnings History for Galena Biopharma (NASDAQ:GALE)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/7/2016        
8/9/2016Q216($0.06)$0.05ViewN/AView Earnings Details
5/10/2016Q1($0.06)($0.07)ViewListenView Earnings Details
3/10/2016Q4($0.05)($0.07)$2.61 millionViewListenView Earnings Details
11/9/2015Q315($0.07)($0.11)$4.22 millionViewListenView Earnings Details
8/6/2015Q215($0.09)($0.10)$3.54 million$3.38 millionViewN/AView Earnings Details
5/7/2015Q115($0.09)($0.08)$3.47 million$2.75 millionViewListenView Earnings Details
3/5/2015Q414($0.11)($0.06)$2.58 million$3.20 millionViewN/AView Earnings Details
11/3/2014Q314($0.11)($0.05)$2.66 million$1.60 millionViewN/AView Earnings Details
8/11/2014Q214($0.09)($0.17)$2.99 million$2.30 millionViewN/AView Earnings Details
5/6/2014Q1($0.10)($0.02)$2.09 million$2.17 millionViewN/AView Earnings Details
3/17/2014Q413($0.09)($0.46)$1.62 million$1.32 millionViewN/AView Earnings Details
8/8/2013Q213($0.10)($0.11)ViewN/AView Earnings Details
3/12/2013Q4 2012($0.62)($0.53)ViewN/AView Earnings Details
11/13/2012Q312($0.09)($0.09)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Galena Biopharma (NASDAQ:GALE)
Current Year EPS Consensus Estimate: $-0.14 EPS
Next Year EPS Consensus Estimate: $-0.14 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20162($0.05)($0.05)($0.05)
Q2 20161($0.08)($0.08)($0.08)
Q3 20161($0.04)($0.04)($0.04)
Q4 20162($0.06)($0.03)($0.05)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Galena Biopharma (NASDAQ:GALE)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Galena Biopharma (NASDAQ:GALE)
Insider Ownership Percentage: 2.02%
Institutional Ownership Percentage: 14.42%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
2/12/2014Richard ChinDirectorSell187,500$4.33$811,875.00View SEC Filing  
2/7/2014Rudolph NisiDirectorBuy20,000$4.94$98,800.00View SEC Filing  
1/30/2014Mark SchwartzCOOSell100,000$5.57$557,000.00View SEC Filing  
1/30/2014Sanford HillsbergDirectorSell250,000$5.41$1,352,500.00View SEC Filing  
1/29/2014Rudolph NisiDirectorSell250,000$5.28$1,320,000.00View SEC Filing  
1/22/2014Steven KriegsmanDirectorSell450,000$6.52$2,934,000.00View SEC Filing  
1/17/2014Rudolph NisiDirectorSell200,000$6.90$1,380,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Galena Biopharma (NASDAQ:GALE)
DateHeadline
investingnews.com logoGalena Biopharma to Present NeuVax™ (nelipepimut-S) Interim Safety Data at ESMO 2016 (NASDAQ:GALE)
investingnews.com - September 30 at 10:13 AM
reuters.com logoBRIEF-Galena biopharma - currently enrolling HER2 1+ and 2+ node positive (NASDAQ:GALE)
www.reuters.com - September 29 at 5:01 PM
smarteranalyst.com logoStock Update (NASDAQ:GALE): Galena Biopharma Inc Presents GALE-301 Folate Binding Protein Expression Data at ... - Smarter Analyst (NASDAQ:GALE)
www.smarteranalyst.com - September 29 at 10:08 AM
News IconMover to Watch: Galena Biopharma, Inc. (NASDAQ:GALE), MDC Partners Inc. (NASDAQ:MDCA) - Newburgh Press (NASDAQ:GALE)
newburghpress.com - September 29 at 10:08 AM
finance.yahoo.com logoGalena Biopharma to Present NeuVax™ (nelipepimut-S) Interim Safety Data at the European Society for Medical Oncology (ESMO) 2016 Congress (NASDAQ:GALE)
finance.yahoo.com - September 29 at 10:08 AM
streetinsider.com logoGalena Biopharma (GALE) Announces GALE-301 Folate Binding Protein Expression Data (NASDAQ:GALE)
www.streetinsider.com - September 28 at 10:02 AM
finance.yahoo.com logoGalena Biopharma Presents GALE-301 Folate Binding Protein Expression Data at the CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference (NASDAQ:GALE)
finance.yahoo.com - September 27 at 5:08 PM
News IconHot Biotech Stocks Recap: Galena Biopharma, Inc. (NASDAQ:GALE), Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN) - The Voice Registrar (NASDAQ:GALE)
voiceregistrar.com - September 26 at 5:20 PM
News IconKeen Investors Find News on Galena Biopharma, Inc. (NASDAQ:GALE) - Duncan Research (NASDAQ:GALE)
www.duncanindependent.com - September 24 at 4:52 PM
News IconGalena Biopharma Inc (NASDAQ:GALE) & salesforce.com, inc. (NYSE:CRM) Watch List - Money News (NASDAQ:GALE)
www.newsismoney.com - September 24 at 4:52 PM
News IconGalena Biopharma, Inc. (NASDAQ:GALE) Insider Trading Report - Newburgh Press (NASDAQ:GALE)
newburghpress.com - September 24 at 4:52 PM
News IconHot Biotech Stocks Recap: Galena Biopharma, Inc. (NASDAQ:GALE ... - The Voice Registrar (NASDAQ:GALE)
voiceregistrar.com - September 24 at 4:52 PM
News IconUnder the Microscope, Zeroing in at Galena Biopharma, Inc. (NASDAQ:GALE) - Duncan Research (NASDAQ:GALE)
www.duncanindependent.com - September 22 at 5:14 PM
News IconBiotech Stocks Worth Chasing: Northwest Biotherapeutics, Inc. (NWBO), Galena Biopharma, Inc. (GALE) - The Independent Republic (NASDAQ:GALE)
theindependentrepublic.com - September 22 at 10:43 AM
News IconMover to Watch - Galena Biopharma, Inc.'s (GALE) - Hot Stocks Point (NASDAQ:GALE)
www.hotstockspoint.com - September 22 at 10:43 AM
News IconHC Stocks in Front Line! Geron Corporation (GERN), Galena ... - share market updates (press release) (NASDAQ:GALE)
sharemarketupdates.com - September 22 at 10:43 AM
News IconIntraday Active Biotech Stocks News: Vitae Pharmaceuticals, Inc. (NASDAQ:VTAE), Galena Biopharma, Inc. (NASDAQ ... - The Voice Registrar (NASDAQ:GALE)
voiceregistrar.com - September 20 at 10:16 AM
News IconTrader's Roundup: Galena Biopharma, Inc. (NASDAQ:GALE), Valley National Bancorp (NYSE:VLY) - Newburgh Press (NASDAQ:GALE)
newburghpress.com - September 20 at 10:16 AM
News IconGalena Biopharma to Present at the Sachs Associates 16th Annual Biotech in Europe Forum - EconoTimes (NASDAQ:GALE)
www.econotimes.com - September 20 at 10:16 AM
finance.yahoo.com logoGalena Biopharma to Present at the Sachs Associates 16th Annual Biotech in Europe Forum (NASDAQ:GALE)
finance.yahoo.com - September 20 at 10:16 AM
investopedia.com logoGalena Wins Exclusive Japanese Patent (GALE) (NASDAQ:GALE)
www.investopedia.com - September 19 at 5:15 PM
News IconResearch Reports on Biotech Equities -- Galena Biopharma, Mast Therapeutics, Medivation, and Amgen (NASDAQ:GALE)
www.kait8.com - September 18 at 4:54 PM
News Icon2 Biotech Stocks News And Price Trends: Galena Biopharma, Inc. (NASDAQ:GALE), bluebird bio, Inc. (NASDAQ:BLUE) - The Voice Registrar (NASDAQ:GALE)
voiceregistrar.com - September 18 at 9:42 AM
News IconNews review of 2 biotech stocks: Geron Corporation (NASDAQ:GERN), Galena Biopharma, Inc. (NASDAQ:GALE) - The Voice Registrar (NASDAQ:GALE)
voiceregistrar.com - September 16 at 4:59 PM
News IconKeen Investors Seek Information on Galena Biopharma, Inc. (NASDAQ:GALE) - Duncan Research (NASDAQ:GALE)
www.duncanindependent.com - September 16 at 4:59 PM
News IconHC Stocks Alerts= Geron Corporation (GERN), Galena Biopharma Inc (NASDAQ:GALE) - share market updates (press release) (NASDAQ:GALE)
sharemarketupdates.com - September 15 at 5:30 PM
News IconStocks Rallying on Investment Valuation: Galena Biopharma, Inc. (NASDAQ:GALE), ImmunoCellular Therapeutics, Ltd ... - Street Wise Report (press release) (blog) (NASDAQ:GALE)
streetwisereport.com - September 14 at 9:24 AM
News IconHot Biotech Stocks Recap: Galena Biopharma, Inc. (NASDAQ:GALE), Radius Health, Inc. (NASDAQ:RDUS) - The Voice Registrar (NASDAQ:GALE)
voiceregistrar.com - September 14 at 9:24 AM
News IconHC Stocks Highlights= ZIOPHARM Oncology Inc. (ZIOP), Galena Biopharma Inc (NASDAQ:GALE) - share market updates (press release) (NASDAQ:GALE)
sharemarketupdates.com - September 14 at 9:24 AM
News IconGalena Biopharma, Inc. Pipeline Reviews and Clinical Trail Assessment 2016- Market Share, and Forecasts - Medgadget (blog) (NASDAQ:GALE)
www.medgadget.com - September 14 at 9:24 AM
smarteranalyst.com logoCompany Update (NASDAQ:GALE): Galena Biopharma Inc Presents Preclinical NeuVax™ Data in Ovarian and ... - Smarter Analyst (NASDAQ:GALE)
www.smarteranalyst.com - September 14 at 9:24 AM
reuters.com logoBRIEF-Galena Biopharma Inc presents preclinical Neuvax data in Ovarian and... - Reuters (NASDAQ:GALE)
www.reuters.com - September 14 at 9:24 AM
globenewswire.com logoGalena Biopharma to Present at the 2016 Aegis Growth Conference - GlobeNewswire (press release) (NASDAQ:GALE)
globenewswire.com - September 14 at 9:24 AM
finance.yahoo.com logo9:51 am Galena Biopharma presents preclinical NeuVax (nelipepimut-S) data in ovarian and pancreatic cancer at the Progress in Vaccination Against Cancer Conference (NASDAQ:GALE)
finance.yahoo.com - September 14 at 9:24 AM
finance.yahoo.com logoGalena Biopharma to Present at the 2016 Aegis Growth Conference (NASDAQ:GALE)
finance.yahoo.com - September 14 at 9:24 AM
News IconKeloid Treatment Market Revenue and Value Chain 2016-2026 (NASDAQ:GALE)
www.pressbox.co.uk - September 13 at 9:57 AM
smarteranalyst.com logoCompany Update (NASDAQ:GALE): Galena Biopharma Inc Expands GALE-401 Intellectual Property Protection with Patent Issuance in Japan (NASDAQ:GALE)
www.smarteranalyst.com - September 13 at 9:57 AM
finance.yahoo.com logoGalena Biopharma Presents Preclinical NeuVax™ (nelipepimut-S) Data in Ovarian and Pancreatic Cancer at the Progress in Vaccination Against Cancer (PIVAC) Conference (NASDAQ:GALE)
finance.yahoo.com - September 13 at 9:57 AM
globenewswire.com logoGalena Biopharma Expands GALE-401 Intellectual Property Protection with Patent Issuance in Japan - GlobeNewswire (press release) (NASDAQ:GALE)
globenewswire.com - September 12 at 4:57 PM
finance.yahoo.com logoGalena Biopharma Expands GALE-401 Intellectual Property Protection with Patent Issuance in Japan (NASDAQ:GALE)
finance.yahoo.com - September 12 at 9:57 AM
News IconBiotech Stocks Worth a Closer Look: Galena Biopharma, Inc ... - The Voice Registrar (NASDAQ:GALE)
voiceregistrar.com - September 9 at 9:54 AM
News IconBiotechnology Stocks in Limelight: PDL BioPharma Inc (NASDAQ:PDLI), Galena Biopharma Inc (NASDAQ:GALE) - Post Registrar (NASDAQ:GALE)
postregistrar.com - September 9 at 9:54 AM
finance.yahoo.com logoGalena Biopharma to Present at the Rodman & Renshaw 18th Annual Global Investment Conference (NASDAQ:GALE)
finance.yahoo.com - September 9 at 9:54 AM
biz.yahoo.com logoGALENA BIOPHARMA, INC. Files SEC form 8-K, Change in Directors or Principal Officers (NASDAQ:GALE)
biz.yahoo.com - September 8 at 5:01 PM
News IconAnalyst Recommendation about Healthcare Stocks: Teva Pharmaceutical Industries Limited (NYSE:TEVA) , Galena (NASDAQ:GALE)
magseriesusa.net - September 3 at 9:48 AM
News IconHot Biotech Stocks Recap: Novavax, Inc. (NASDAQ:NVAX), Galena Biopharma, Inc. (NASDAQ:GALE) - The Voice Registrar (NASDAQ:GALE)
voiceregistrar.com - September 1 at 8:01 AM
News IconHC Stocks to watch for - Galena Biopharma Inc (NASDAQ:GALE), Pfizer Inc. (NYSE:PFE) - share market updates (press release) (NASDAQ:GALE)
sharemarketupdates.com - September 1 at 8:01 AM
News IconAnalyst Views on Price Target: Galena Biopharma Inc (NASDAQ ... - Post Registrar (NASDAQ:GALE)
postregistrar.com - August 28 at 9:36 AM
News IconGalena Biopharma Inc (NASDAQ:GALE) Could Easily Turn Around Near Term (NASDAQ:GALE)
streetregister.com - August 27 at 9:44 AM
News IconTrading the Biotech News: Stemline Therapeutics, Inc. (NASDAQ:STML), Galena Biopharma, Inc. (NASDAQ:GALE) - The Voice Registrar (NASDAQ:GALE)
voiceregistrar.com - August 26 at 8:06 AM

Social

Galena Biopharma (NASDAQ:GALE) Chart for Friday, September, 30, 2016


Last Updated on 9/30/2016 by MarketBeat.com Staff